Windlass Biotech gets CDSCO Panel Nod To Manufacture, Market Ezetimibe plus Atorvastatin Calcium tablet Dr. Divya Colin4 Feb 2024 6:00 PM ISTNew Delhi: In response to the proposal presented by the drug major Windlas Biotech, the Subject Expert Committee (SEC) functional under the Central...
Add geographically distributed Govt sites: CDSCO Panel tells Dr Reddy's on antirheumatic drug Abatacept study Dr. Divya Colin3 Feb 2024 6:00 PM ISTNew Delhi: The drug major Dr Redyy's Laboratories has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
Novartis Gets CDSCO Panel Nod to Study XXB750 in Patients With Heart Failure Dr. Divya Colin2 Feb 2024 6:00 PM ISTNew Delhi: The drug major Novartis has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Intas Pharma Gets CDSCO Panel Nod to Study anti-cancer Drug Lipid Based Cabazitaxel Dr. Divya Colin1 Feb 2024 6:00 PM ISTNew Delhi: Citing that the firm should include an adequate number of government hospital trial sites, the Subject Expert Committee (SEC) functional...
Novo Nordisk Gets CDSCO Panel conditional nod to study Insulin icodec Dr. Divya Colin31 Jan 2024 6:00 PM ISTNew Delhi: The drug major Novo Nordisk has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Sun Pharma gets CDSCO Panel Nod To study Leuprolide acetate for depot suspension Dr. Divya Colin30 Jan 2024 6:00 PM ISTNew Delhi: The drug major Sun Pharma has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Justify proposed dose and rationality: CDSCO Panel Tells Lupin on FDC Sacubitril plus Valsartan Dr. Divya Colin29 Jan 2024 6:00 PM ISTNew Delhi: In response to the proposal presented by the drug major Lupin for the fixed-dose combination (FDC) cardiovascular drug Sacubitril plus...
Biological E gets CDSCO Panel Nod To study vaccine for 6- 8 weeks old infants Dr. Divya Colin28 Jan 2024 6:00 PM ISTNew Delhi: Reviewing the Phase I clinical trial report, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Roche's proposal for marketing Atezolizumab Injection for Subcutaneous route rejected by CDSCO Panel Dr. Divya Colin27 Jan 2024 6:00 PM ISTNew Delhi: Rejecting the drug major Roche's proposal to market the anti-cancer drug Atezolizumab Injection (1875mg/15ml vial) (Tecentriq) for a new...
Micro Lab Gets CDSCO panel Nod To Manufacture and Market Ebastine plus Phenylephrine FDC Dr. Divya Colin26 Jan 2024 6:00 PM ISTNew Delhi: Micro Labs has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation...
Novo Nordisk Gets CDSCO Panel Nod to Study Ziltivekimab Dr. Divya Colin25 Jan 2024 6:00 PM ISTNew Delhi: The drug major Novo Nordisk has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
CDSCO Drug Alert: 78 Drug Samples including Alkem's Pan 40 Flagged Dr. Divya Colin24 Jan 2024 6:17 PM ISTNew Delhi: In its latest drug safety alert, the apex drug regulatory body, Central Drug Standard Control Organisation (CDSCO) has flagged 78 medicine...
